Non-peptidic CRF1 receptor antagonists for the treatment of anxiety, depression and stress disorders.

Current drug targets. CNS and neurological disorders

Volumn 1, Issue 5, 2002, Pages 467-493

  Kehne, J ^a   De Lombaert, S ^a  

^a NEUROGEN CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN RELEASING FACTOR RECEPTOR; CRF RECEPTOR TYPE 1;

ANIMAL; ANXIETY DISORDER; CLINICAL TRIAL; DEPRESSION; DRUG ANTAGONISM; DRUG SCREENING; HUMAN; METHODOLOGY; PHYSIOLOGY; POSTTRAUMATIC STRESS DISORDER; PSYCHOLOGICAL ASPECT; REVIEW; STATISTICS;

ANIMALS; ANXIETY DISORDERS; CLINICAL TRIALS; DEPRESSIVE DISORDER; DRUG EVALUATION, PRECLINICAL; HUMANS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STRESS DISORDERS, TRAUMATIC;

MLCS; MLOWN;

EID: 0037844639     PISSN: 1568007X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568007023339049     Document Type: Review

References (297)